The global hunter syndrome treatment market is estimated to grow at a CAGR of around 5% during the forecast period. Hunter syndrome is also known as Mucopolysaccharidosis type II or MSP II. It is a very rare genetic disorder caused by the malfunction of the enzyme. Hunter syndrome happens due to the deficiency of the enzyme.
Please read the originial post here: https://www.omrglobal.com/industry-reports/hunter-syndrome-treatment-market